1887

Abstract

Purpose. Nontypeable Haemophilus influenzae (NTHi) is a commensal in the human nasopharynx and the cause of pneumonia, meningitis, sinusitis, acute exacerbations of chronic obstructive pulmonary disease and acute otitis media (AOM). AOM is the most common ailment for which antibiotics are prescribed in the United States. With the emergence of new strains of antibiotic-resistant bacteria, finding an effective and broad coverage vaccine to protect against AOM-causing pathogens has become a priority. Mouse models are a cost-effective and efficient way to help determine vaccine efficacy. Here, we describe an NTHi AOM model in C57BL/6J mice, which also utilizes a mouse-adapted H1N1 influenza virus to mimic human coinfection.

Methodology. We tested our coinfection model using a protein vaccine formulation containing protein D, a well-studied NTHi vaccine candidate that can be found in the 10-valent Streptococcus pneumoniae conjugate vaccine. We verified the usefulness of our mouse model by comparing bacterial loads in the nose and ear between protein D-vaccinated and control mice.

Results. While there was no measurable difference in nasal bacterial loads, we did detect significant differences in the bacterial loads of ear washes and ear bullae between vaccinated and control mice.

Conclusion. The results from this study suggest that our NTHi AOM coinfection model is useful for assessing protein vaccines.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000827
2018-08-23
2019-08-22
Loading full text...

Full text loading...

References

  1. Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 2008;359:2355–2365 [CrossRef][PubMed]
    [Google Scholar]
  2. Hayes D, Meyer KC. Acute exacerbations of chronic bronchitis in elderly patients. Drugs Aging 2007;24:555–572 [CrossRef]
    [Google Scholar]
  3. Murphy TF. The role of bacteria in airway inflammation in exacerbations of chronic obstructive pulmonary disease. Curr Opin Infect Dis 2006;19:225–230 [CrossRef][PubMed]
    [Google Scholar]
  4. Klein JO. Otitis media. Clin Infect Dis 1994;19:823–833 [CrossRef][PubMed]
    [Google Scholar]
  5. National Institute on Deafness and Other Communication Disorders Health Info, Hearing, Ear, Infection and Deafness, Otitis Media (Ear Infection) [Internet]. NIH 2002
    [Google Scholar]
  6. Kaur R, Morris M, Pichichero ME. Epidemiology of acute otitis media in the postpneumococcal conjugate vaccine era. Pediatrics 2017;140:e20170181 [CrossRef][PubMed]
    [Google Scholar]
  7. Groves F, Sinha D, Auvinen A. Haemophilus influenzae type b vaccine formulation and risk of childhood leukaemia. Br J Cancer 2002;87:511–512 [CrossRef][PubMed]
    [Google Scholar]
  8. Murphy TF. Vaccines for nontypeable Haemophilus influenzae: the future is now. Clin Vaccine Immunol 2015;22:459–466 [CrossRef][PubMed]
    [Google Scholar]
  9. Behrouzi A, Vaziri F, Rahimi-Jamnani F, Afrough P, Rahbar M et al. Vaccine candidates against nontypeable Haemophilus influenzae: a review. Iran Biomed J 2017;21:69–76 [CrossRef][PubMed]
    [Google Scholar]
  10. Langereis JD, Stol K, Schweda EK, Twelkmeyer B, Bootsma HJ et al. Modified lipooligosaccharide structure protects nontypeable Haemophilus influenzae from IgM-mediated complement killing in experimental otitis media. mBio 2012;3:e00079–12 [CrossRef][PubMed]
    [Google Scholar]
  11. Demaria TF, Murwin DM, Leake ER. Immunization with outer membrane protein P6 from nontypeable Haemophilus influenzae induces bactericidal antibody and affords protection in the chinchilla model of otitis media. Infect Immun 1996;64:5187–5192[PubMed]
    [Google Scholar]
  12. Giebink GS, Payne EE, Mills EL, Juhn SK, Quie PG. Experimental otitis media due to Streptococcus pneumoniae: immunopathogenic response in the chinchilla. J Infect Dis 1976;134:595–604 [CrossRef][PubMed]
    [Google Scholar]
  13. Giebink GS. Otitis media: the chinchilla model. Microbial Drug Resistance 1999;5:57–72 [CrossRef]
    [Google Scholar]
  14. Apicella MA. Bacterial otitis media, the chinchilla middle ear, and biofilms. J Infect Dis 2009;199:774–775 [CrossRef][PubMed]
    [Google Scholar]
  15. Poolman JT, Bakaletz L, Cripps A, Denoel PA, Forsgren A et al. Developing a nontypeable Haemophilus influenzae (NTHi) vaccine. Vaccine 2000;19:S108–S115 [CrossRef][PubMed]
    [Google Scholar]
  16. Parkinson N, Hardisty-Hughes RE, Tateossian H, Tsai HT, Brooker D et al. Mutation at the Evi1 locus in Junbo mice causes susceptibility to otitis media. PLoS Genet 2006;2:e149 [CrossRef][PubMed]
    [Google Scholar]
  17. Croxtall JD, Keating GM. Pneumococcal polysaccharide protein D-conjugate vaccine (Synflorix; PHiD-CV). Paediatr Drugs 2009;11:349–357 [CrossRef][PubMed]
    [Google Scholar]
  18. Bakaletz LO, Tallan BM, Hoepf T, Demaria TF, Birck HG et al. Frequency of fimbriation of nontypable Haemophilus influenzae and its ability to adhere to chinchilla and human respiratory epithelium. Infect Immun 1988;56:331–335[PubMed]
    [Google Scholar]
  19. Khan MN, Xu Q, Pichichero ME. Protection against Streptococcus pneumoniae invasive pathogenesis by a protein-based vaccine is achieved by suppression of nasopharyngeal bacterial density during influenza A virus coinfection. Infect Immun 2017;85: [CrossRef][PubMed]
    [Google Scholar]
  20. Khan MN, Pichichero ME. CD4 T cell memory and antibody responses directed against the pneumococcal histidine triad proteins PhtD and PhtE following nasopharyngeal colonization and immunization and their role in protection against pneumococcal colonization in mice. Infect Immun 2013;81:3781–3792 [CrossRef][PubMed]
    [Google Scholar]
  21. Ryan AF, Ebmeyer J, Furukawa M, Pak K, Melhus A et al. Mouse models of induced otitis media. Brain Res 2006;1091:3–8 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000827
Loading
/content/journal/jmm/10.1099/jmm.0.000827
Loading

Data & Media loading...

Supplementary File 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error